QuoTrend
DashboardScreenCompareStrategiesPortfolioSectorsHeatmapsInsiderFuturesForexCryptoCalendarNews
DashboardScreenCompareStrategiesPortfolioSectorsHeatmapsInsiderFuturesForexCryptoCalendarNewsMore
⌘K
Help
QuoTrend
PAGEHome
HomePricingContactHelpTermsPrivacy
Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
© 2026 QuoTrend
Screen

ZBIO

QT67Zenas BioPharma, Inc.
NASDAQ·Healthcare·Biotechnology·USA
Latest market price
19.78
+1.20+6.46%
OverviewShort InterestFilings
ZBIOQT67Zenas BioPharma, Inc.·NASDAQ
OverviewShort InterestFilings
19.78+6.46%
TA
Loading chart...
Screen all →
VRTX-1.60%$451.63REGN+0.33%$609.94ARGX-1.63%$877.72ALNY-1.64%$278.09RVMD+3.31%$162.99MRNA+3.50%$63.96UTHR-2.70%$536.59BNTX-1.44%$90.89
Snapshot
Index-P/E-EPS (ttm)
-
Insider Own-
Shs Outstand-
Perf Week11.37%
Market Cap829.46MForward P/E-EPS next Y-4.73Insider Trans-Shs Float-Perf Month10.87%
Enterprise Value680.97MPEG0.03EPS next Q-0.89Inst Own-Short Float-Perf Quarter-15.36%
Income-341241606.00P/S0.00EPS this Y-Inst Trans-Short Ratio-Perf Half Y-46.38%
Sales-P/B3.08EPS next Y1.67%ROA-56.86%Short Interest-Perf YTD-45.52%
Book/sh-P/C-EPS next 5Y-ROE-167.71%52W High44.60 -55.65%Perf Year104.34%
Cash/sh-P/FCF-EPS past 3/5Y-ROIC-61.53%52W Low8.91 122.00%Perf 3Y-
Dividend Est.-EV/EBITDA-1.67Sales past 3/5Y-Gross Margin0.00%Volatility5.59% 4.58%Perf 5Y-
Dividend TTM-EV/Sales0.00EPS Y/Y TTM-33.78%Oper. Margin0.00%ATR (14)1.41Perf 10Y-
Dividend Ex-Date-Quick Ratio11.94Sales Y/Y TTM-Profit Margin0.00%RSI (14)55.36Recom2.20
Dividend Gr. 3/5Y-Current Ratio11.94EPS Q/Q-82.50%SMA207.53%Beta1.26Target Price35.00
Payout0.00%Debt/Eq1.05Sales Q/Q-100.00%SMA502.95%Rel Volume3.76Prev Close18.58
Employees130LT Debt/Eq0.33EarningsAug 11SMA200-19.88%Avg Volume565.31KPrice19.78
IPO DateSep 13, 2024Option/ShortYes / YesEPS/Sales Surpr.-6.57% -Net Debt/EBITDA0.36Volume2,128,224Change6.46%
Analyst Ratings
DateActionAnalystRatingTarget
May-14-26ReiteratedMorgan StanleyEqual Weight$19 → $22
Jan-06-26ReiteratedJefferies$52 → $48
Jan-06-26DowngradeMorgan StanleyOverweight → Equal Weight$19
Oct-28-25ReiteratedH.C. Wainwright$30 → $44
Oct-27-25ReiteratedJefferies$35 → $52
Oct-08-24InitiatedJefferiesBuy$35
Latest News
Jun-12-26
Jun-12-2608:02AM
Lennar Reports Mixed Q2 Results, Joins Adobe And Other Big Stocks Moving Lower In Friday's Pre-Market SessionBenzinga
Company
Ownership

Per-holder 13F data hasn't been ingested for this ticker yet.

Financial Statements
DataTimeframe
Line Item (USD, M)
FY 2025
12/31/2025
FY 2024
12/31/2024
FY 2023
12/31/2023
FY 2022
12/31/2022
Total Revenue10550
Upgrade your experience to unlock full historical data
Cost of Goods Sold Incl. D&A01390
Gross Profit10-13450
Selling, General and Administrative Excl. Other533017
Research and Development16813960
Other Operating Expense0-13910
Operating Income-211-164-37
Interest Expense700
Unusual Expense
———
Non-Operating Income (Expense)159-7-10
Net Income Before Taxes-378-157-37
Income Taxes
000
Consolidated Net Income-378-157-37
Net Income From Continuing Operations-378-157-37
Net Income-378-157-37
EPS (Recurring)-8.44-3.76-0.97
EPS (Basic, Before Extraordinaries)-8.44-3.76-0.97
EPS (Diluted)-8.44-3.76-0.97
EBITDA-370-156-27
Other After Tax Adjustments
———
Stock Option Compensation Expense
———
Price To Earnings Ratio
———
Price To Sales Ratio163.40——
Gross Margin100.00-2,680.00100.00
Operating Margin-2,110.00-3,280.00-74.00
Net Margin-3,780.00-3,140.00-74.00
Shares Outstanding454238
Market Capitalization1,634——
Operating Lease Expense
———
Insider Trading Volume
$21.93$18.48$15.04$11.60$8.15● Close Price0.00M4.41M8.81M13.22M17.63MUSD Trades VolumeJunJulAugSepOctNovDec2026FebMarAprMayJun
Insider Trading
InsiderRelationshipDateTransactionCost#SharesValue ($)#Shares TotalSEC Form 4
MOULDER LEON O JRChief Executive OfficerMay 18 '26Buy16.8860,0001,012,80096,928May 18 12:00 AM
MOULDER LEON O JRChief Executive OfficerApr 29 '26Buy17.6235,000616,7001,786,039Apr 29 12:00 AM
MOULDER LEON O JRChief Executive OfficerApr 28 '26Buy18.0225,000450,5001,751,039Apr 29 12:00 AM
Lu HongboDirectorMar 31 '26Buy19.9378,7681,570,198426,736Apr 02 12:00 AM
Fairmount Funds Management LLCDirectorMar 31 '26Buy20.00150,0003,000,0002,359,025Apr 01 12:00 AM
MOULDER LEON O JRChief Executive OfficerMar 31 '26Buy19.3134,000656,5401,726,039Mar 31 12:00 AM
MOULDER LEON O JRChief Executive OfficerMar 30 '26Buy18.2320,000364,6001,692,039Mar 31 12:00 AM
Allen Patricia LDirectorFeb 13 '26Buy26.364,160109,65819,860Feb 13 12:00 AM
Allen Patricia LDirectorFeb 12 '26Buy24.8515,700390,08815,700Feb 13 12:00 AM
Lu HongboDirectorFeb 11 '26Buy22.5025,985584,663347,968Feb 13 12:00 AM
MOULDER LEON O JRChief Executive OfficerFeb 02 '26Buy17.9657,0001,023,720423,155Feb 03 12:00 AM
MOULDER LEON O JRChief Executive OfficerJan 09 '26Buy16.5520,000331,000366,155Jan 09 12:00 AM
MOULDER LEON O JRChief Executive OfficerJan 08 '26Buy16.3030,000489,000346,155Jan 09 12:00 AM
MOULDER LEON O JRChief Executive OfficerJan 07 '26Buy16.3850,000819,000316,155Jan 09 12:00 AM
Nunn Jason RaleighDirectorOct 09 '25Buy19.0063,1581,200,0021,173,395Oct 14 12:00 AM
open in yahoo·open in reuters·open in marketwatch·open in google·open in EDGAR